Congenital glaucoma is a rare eye condition present at birth in which fluid inside the eye cannot drain properly, causing pressure to build up and damage the optic nerve. It affects roughly 1 in 10,000 to 18,000 live births and is the most common type of glaucoma in infants. Because a baby’s eye is still soft and elastic, that rising pressure can actually stretch the entire eyeball, making early detection and treatment critical for preserving vision.
What Happens Inside the Eye
The eye constantly produces a clear fluid that nourishes its internal structures and then drains out through a tiny mesh of tissue near the front of the eye. In congenital glaucoma, this drainage tissue does not develop correctly before birth. The fluid has nowhere to go, so pressure inside the eye climbs above the normal infant range of 10 to 15 mmHg.
Unlike adult glaucoma, where high pressure mainly damages the optic nerve over years, the pressure in an infant’s eye can deform the eyeball itself. The cornea (the clear front surface) stretches and swells, and the whole eye can enlarge visibly, a condition called buphthalmos. Tiny cracks can form in the inner layers of the cornea from this stretching, leaving permanent lines that eye doctors use as a diagnostic clue.
Signs Parents Notice First
Congenital glaucoma produces a recognizable set of three symptoms: excessive tearing, sensitivity to light, and involuntary squeezing of the eyelids shut. These happen because the swollen cornea irritates the eye’s surface. A baby with congenital glaucoma may cry or turn away in bright light, keep one or both eyes clenched, and have tears streaming even when not upset.
One detail that helps distinguish this from a blocked tear duct, which is extremely common in newborns, is that congenital glaucoma causes tearing without any thick or sticky discharge. A blocked tear duct typically produces mucus or crusting around the eye. Parents may also notice that one eye looks larger than the other or that the cornea appears cloudy or hazy rather than clear. A corneal diameter larger than 12 mm in the first year of life suggests the eye is enlarging under abnormal pressure.
Who Is at Higher Risk
Congenital glaucoma runs in families and follows an autosomal recessive inheritance pattern, meaning a child needs to inherit a copy of the affected gene from each parent. Three genes have been identified so far. The most well-studied is CYP1B1, which was the first gene linked to the condition. Mutations in this gene appear to disrupt normal development of the eye’s drainage structures during pregnancy.
Incidence varies significantly by population. In the general European population, rates hover around 5 per 100,000 births. But in communities with high rates of marriage between close relatives, the numbers climb dramatically. Among Roma populations in Romania, for instance, the rate reaches 80 per 100,000, roughly 15 times the general European average. Consanguinity (parents who are closely related) is one of the strongest known risk factors. Most cases appear without a family history, however, because both parents can silently carry a single copy of the gene without ever having symptoms themselves.
How It Is Diagnosed
Pediatricians can catch early signs during routine newborn exams by looking for a cloudy cornea, an enlarged eye, or excessive tearing with light sensitivity. If congenital glaucoma is suspected, the infant is referred to a pediatric ophthalmologist for a full evaluation, which often requires examination under anesthesia so the doctor can measure eye pressure, corneal diameter, and inspect the drainage angle directly.
Normal corneal diameter in a full-term newborn is 9.5 to 10.5 mm. Anything above 12 mm in the first year raises concern. The doctor also looks for optic nerve damage, corneal swelling, and those characteristic stretch marks on the inner cornea. If other eye abnormalities or broader medical conditions are present, such as certain facial birthmarks or lens abnormalities, the diagnosis shifts from primary congenital glaucoma to a secondary form, which may need a different treatment approach.
Surgery Is the Primary Treatment
Unlike adult glaucoma, which is typically managed first with eye drops, congenital glaucoma almost always requires surgery. The goal is to open or bypass the malformed drainage tissue so fluid can flow out of the eye normally. Two main procedures are used as first-line options: one involves making a small cut in the drainage tissue from inside the eye, and the other approaches it from the outside. Both create a new pathway for fluid to escape.
Success rates depend heavily on severity. For mild cases, both procedures achieve success rates of 81 to 100%, with pressure staying controlled for at least a year after surgery. Moderate cases are trickier. The internal approach controls pressure in only about 13% of moderate cases, while the external approach succeeds in about 40%. A combined procedure that creates both an internal and external drainage pathway, along with a medication to prevent scarring, pushes that number to 80%.
Severe cases are the most challenging. The external approach alone controls pressure in just 10% of severe eyes after two years. The combined procedure manages about 70%. This means many children with moderate or severe disease will need more than one surgery over their lifetime. In one long-term study following patients for an average of about seven years, 56% of eyes required a second procedure on a different area of the drainage tissue, and some patients eventually needed an artificial drainage device implanted.
The Role of Eye Drops
Medications play a supporting role, either to lower pressure temporarily before surgery or to manage pressure that creeps back up afterward. The most commonly used drops reduce how much fluid the eye produces. These are generally well tolerated in infants, though dosing must be carefully adjusted for a baby’s small body weight since the medication can be absorbed into the bloodstream.
One class of drops used in adults is actually contraindicated in children under age two because of potentially serious side effects, including drowsiness and dangerously slowed breathing. Prostaglandin drops, another common adult glaucoma medication, tend to be less effective at lowering pressure in children than in adults, though they have a good safety profile. Eye drops alone rarely control congenital glaucoma long term, which is why surgery remains the cornerstone of treatment.
Long-Term Vision Outcomes
The reality of congenital glaucoma is that it requires lifelong monitoring. Pressure can rise again years after a successful surgery, and the optic nerve damage that occurs before treatment is permanent. In a long-term follow-up study, 25% of patients achieved vision of 20/40 or better at their final visit, which is sharp enough to pass a standard driver’s license exam. That means the majority of patients do live with some degree of visual impairment, though the range is wide.
Several factors influence the outcome. Children diagnosed and treated within the first few months of life generally do better than those caught later. The severity at diagnosis matters enormously: mild cases respond well to a single surgery and often retain useful vision, while severe cases may require multiple interventions and still face significant visual challenges. Amblyopia (sometimes called “lazy eye”) is a common complication, especially when one eye is more affected than the other, because the brain may start ignoring input from the weaker eye during critical developmental windows.
Children with congenital glaucoma also tend to develop nearsightedness as the stretched eye grows, and they are at higher risk for corneal scarring from the initial swelling and surgical interventions. Regular eye exams, typically every few months in early childhood and at least annually thereafter, are essential for catching pressure spikes, updating corrective lens prescriptions, and treating amblyopia early when patching therapy can still make a difference.